Suppr超能文献

相似文献

1
Spermine synthase engages in macrophages M2 polarization to sabotage antitumor immunity in hepatocellular carcinoma.
Cell Death Differ. 2025 Mar;32(3):573-586. doi: 10.1038/s41418-024-01409-z. Epub 2024 Dec 10.
2
Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma.
Cell Mol Immunol. 2024 Dec;21(12):1505-1521. doi: 10.1038/s41423-024-01231-0. Epub 2024 Nov 4.
4
Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
Cancer Lett. 2021 Aug 10;513:14-25. doi: 10.1016/j.canlet.2021.05.007. Epub 2021 May 14.
5
Tumor-associated macrophage-based predictive and prognostic model for hepatocellular carcinoma.
PLoS One. 2025 Jul 2;20(7):e0325120. doi: 10.1371/journal.pone.0325120. eCollection 2025.
7
Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20/CCR6 axis in human hepatocellular carcinoma.
Cell Mol Immunol. 2024 Oct;21(10):1120-1130. doi: 10.1038/s41423-024-01199-x. Epub 2024 Jun 28.

引用本文的文献

1
Cyclophilin J Reprograms Tumor-associated Macrophages to Exert an Anti-tumor Effect in Liver Cancer.
Int J Biol Sci. 2025 May 31;21(8):3776-3790. doi: 10.7150/ijbs.113197. eCollection 2025.
2
Ubiquitination in hepatocellular carcinoma immunity.
J Transl Med. 2025 May 23;23(1):574. doi: 10.1186/s12967-025-06592-2.

本文引用的文献

1
The tumor-intrinsic role of the mA reader YTHDF2 in regulating immune evasion.
Sci Immunol. 2024 May 31;9(95):eadl2171. doi: 10.1126/sciimmunol.adl2171.
2
Lactate and lactylation: Behind the development of tumors.
Cancer Lett. 2024 Jun 1;591:216896. doi: 10.1016/j.canlet.2024.216896. Epub 2024 Apr 17.
3
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer.
Nat Commun. 2024 Mar 19;15(1):2461. doi: 10.1038/s41467-024-46776-w.
4
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
5
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
Gut. 2023 Nov 24;72(12):2307-2320. doi: 10.1136/gutjnl-2022-329147.
7
Combination immunotherapy for hepatocellular carcinoma.
J Hepatol. 2023 Aug;79(2):506-515. doi: 10.1016/j.jhep.2023.03.003. Epub 2023 Mar 16.
8
Exploring the effect of polyamines on NK cell function in colorectal cancer process based on glycolysis.
Int Immunopharmacol. 2023 Apr;117:109944. doi: 10.1016/j.intimp.2023.109944. Epub 2023 Mar 3.
9
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
J Hepatol. 2023 Apr;78(4):770-782. doi: 10.1016/j.jhep.2023.01.011. Epub 2023 Jan 26.
10
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8 T cells.
Nat Immunol. 2023 Feb;24(2):255-266. doi: 10.1038/s41590-022-01398-6. Epub 2023 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验